Obesity, Diabetes & Metabolic Research in Montana & Utah
Explore Boeson’s obesity and metabolic research expertise in Montana and Utah, including investigator experience with weight-management, diabetes and cardiovascular-risk studies.
Investigator expertise and research experience
Dr. Aubrey Remmers in Missoula combines family-medicine experience with obesity-medicine certification and a PI portfolio spanning obesity, type 1 and type 2 diabetes, and cardiovascular risk. Her research background includes oral and injectable incretin-based therapies. Dr. Jason Andersen in Provo adds extensive psychiatric research experience and a specific interest in obesity and metabolic protocols examining the psychiatric effects of GLP-1 treatments.
Research experience and interests
- Weight management and obesity
- Type 1 and type 2 diabetes
- Metabolic and cardiovascular risk
- Mental health outcomes in GLP-1 research
For volunteers
Weight-loss and diabetes studies can have different requirements for medical history, current medicines and prior treatment. Ask which opportunities are available at your preferred location, what visits involve and how your usual care would be coordinated. A research-interest inquiry is not a prescription or an offer of weight-loss treatment.
Build your Boeson site shortlist
Connect Dr. Remmers’ obesity-medicine expertise and metabolic trial portfolio in Missoula with Dr. Andersen’s psychiatric expertise in Provo. For programs evaluating mental health alongside metabolic outcomes, request a review of their complementary roles and locations. Dr. Andersen’s GLP-1 focus is a research interest supported by his psychiatric background.
Meet the investigators
Explore relevant locations
These links describe location expertise, not a promise of an open study.
Does GLP-1 research mean a treatment is available now?
No. This page describes research experience and interests. Current study availability, eligibility and treatment assignment depend on the individual protocol.
Choose your next step
Contact the local team to ask about current availability, or share a nonconfidential study synopsis for feasibility.
Research experience does not mean a study is currently enrolling. Participation is voluntary; risks and possible benefits are explained through the study-specific consent process. Content updated September 2026.